Related Experiment Video

Updated: Sep 8, 2025

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

13.8K

Progress in research on DDOST dysregulation in related diseases

Haoan Sun1, Chunbao Xie2

  • 1School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.

Glycoconjugate Journal
|July 2, 2025
PubMed

Insights

DDOST protein is crucial for N-glycosylation and linked to diseases like congenital disorders of glycosylation and solid tumors. This review explores DDOST

Area of Science:

  • Biochemistry and Molecular Biology
  • Cellular Biology
  • Disease Mechanisms

Background:

  • DDOST is a key subunit of N-glycosylated oligosaccharyltransferase, vital for protein N-glycosylation.
  • Aberrant DDOST expression is implicated in congenital disorders of glycosylation (CDG) and various solid tumors.
  • Understanding DDOST's role is critical for disease research.

Purpose of the Study:

  • To provide a comprehensive review of DDOST's functions in disease.
  • To summarize DDOST's molecular interactions and involvement in specific diseases.
  • To establish a foundation for future DDOST research.

Main Methods:

  • Literature review and synthesis of existing research on DDOST.
  • Analysis of studies linking DDOST to congenital disorders of glycosylation.
  • Examination of DDOST's role in the progression of solid tumors.

Main Results:

  • DDOST plays a fundamental role in protein N-glycosylation.
  • Evidence links DDOST dysfunction to congenital disorders of glycosylation (DDOST-CDG).
  • DDOST is associated with the development and progression of solid tumors.

Conclusions:

  • DDOST is a significant factor in N-glycosylation and disease pathogenesis.
  • Further investigation into DDOST mechanisms is warranted for therapeutic development.
  • This review consolidates current knowledge on DDOST in disease contexts.
Keywords:
DDOSTCancerCongenital disorders of glycosylationN-glycosylation

More Related Videos

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia10:41

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Published on: September 12, 2020

7.5K
Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases06:52

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases

Published on: September 29, 2014

53.9K

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
702
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.9K